IMCRのPER（株価収益率）は？

IMMUNOCORE HOLDINGS LTD（IMCR）は現在PER 125.24倍で取引されています。

IMCRのROE（自己資本利益率）は？

IMMUNOCORE HOLDINGS LTDのROEは-4.78%です。

IMCRの配当利回りは？

IMMUNOCORE HOLDINGS LTDの配当利回りは0.00%です。

IMCRの品質スコア（Quality Score）は？

当社のAIはIMCRの総合財務品質を100点中38点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。

IMCRは今が買い時ですか？

当社AIのタイミングスコアは100点中89点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。

IMCRはどのセクターに属しますか？

IMMUNOCORE HOLDINGS LTDはHealthcare >> Biotechnologyセクターに分類されます（NASDAQ市場）

IMCR (NASDAQ) 株価分析 | IMMUNOCORE HOLDINGS LTD

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-03-31)

IMCR AI Analysis Summary

Our AI summary for IMCR: IMMUNOCORE HOLDINGS LTD (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 125.24, ROE of -4.78%, a dividend yield of 0.00%. Its financial Quality Score stands at 38/100 — fundamentals below the market average. The AI Timing Score is 89/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

IMCR

IMMUNOCORE HOLDINGS LTD

US:NASDAQ STOCK Healthcare >> Biotechnology News 98

USD 33.81

-0.06 (-0.18%) Day Change

Watchlist Portfolio Compare Chart

125.24

P/E

1.01

D/E

-4.8%

ROE

-1.8%

ROA

0.00%

Div Yield

-7.46

PEG

IMMUNOCORE HOLDINGS LTD
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 33.81 Price -0.06 (-0.18%) Day Change	NEWS SCORE: 98

IMCR, ファンダメンタルスコアはnot good ( ファンダメンタル = 38) but テクニカルスコアは ...(Sign In to See)...

Loading chart...

38 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: P/Eが高い。割高銘柄。
ROEが低い
ROAが低い
ROEの伸びが低い
平均ROEが低い
ROAの伸びが低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...

Deepscope 分析

39%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	98
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	33.81
PBV / Sector	4.38 / 5.20
Earning Per Share	-0.37

PE / Sector	125.24 / 19.97
PEG or PE/Growth / Sector	-7.46 / 1.22
Average 1M Daily Value	19.00 M GREAT
Average 1W Daily Value	11.49 M GREAT

Timing Factors

57%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

43%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ポイントになる統計

54%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-4.88 / 98.71
NPM Average (%) / Sector	-16.50 / -1,721.76
NPM Change Average (%) / Sector	-35.82 / 5,211.62
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-1.76 / 27.02
ROA Average (%) / Sector	-4.77 / -368.17
ROA Change Average (%) / Sector	-30.97 / 5,404.12
ROE (%) / Sector	-4.78 / 3.47
ROE Average (%) / Sector	-9.54 / 6.51
ROE Change Average (%) / Sector	-20.47 / 2,128.13
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

配当

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -1.75

登録情報

Analyze Date	2026-08-01 08:00:00
Symbol	IMCR
Name	IMMUNOCORE HOLDINGS LTD
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	50.87 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	1,722.82 / 9,903.94

ニュース

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 92 Park Drive, Abingdon, United Kingdom, OX14 4RY

Phone: 44 12 3543 8600

Website: https://www.immunocore.com

Employees: 524

Sector: Healthcare >> Biotechnology

Description: Immunocore Holdings plc, together with its subsidiaries, engages in the development and commercialization of immunomodulating medicines for patients with cancer, infectious diseases, and autoimmune disease in the United States, Europe, and internationally. The company offers KIMMTRAK for the treatment of unresectable or metastatic uveal melanoma. It also develops oncology programs, including tebentafusp which is in Phase 3 clinical trial for the treatment of advanced cutaneous melanoma and adjuvant uveal melanoma; brenetafusp which is in Phase 3 clinical trial for the treatment of first-line advanced cutaneous melanoma and in Phase 1/2 clinical trial for the treatment of various tumor types; IMC-R117C which is in Phase 1/2 clinical trial for the treatment of advanced solid tumors, such as colorectal cancer; and IMC-P115C which is in Phase 1 clinical trial for patients with tumors that express PRAME. In addition, the company is involved in the development of IMC-M113V which is in Phase 1 clinical trial for a potential functional cure of human immunodeficiency virus; and IMC-I109V which is in Phase 1 clinical trial for a potential functional cure of hepatitis B virus. Further, it develops IMC-S118AI which is in pre-investigation stage for the treatment of type 1 diabetes; and IMC-U120AI which is in pre-investigation stage for the treatment of atopic dermatitis. The company was founded in 1999 and is headquartered in Abingdon, the United Kingdom.